ICCC
ImmuCell Corporation
10.00$
-0.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +34.6% | -6.7% | +9.3% | +5.3% | +24.9% | +11.8% | +25.4% | -3.5% | -5.9% | +51.6% | +4.3% | |
| – | +26.4% | +3.7% | +26.4% | +11.2% | +20.6% | +21.4% | +24.9% | +3.1% | +19.7% | +41.9% | -12.7% | |
| – | +40.5% | -13.3% | -3.7% | -0.5% | +29.8% | +1.8% | +26.1% | -11.6% | -42.5% | +80.6% | +44.1% | |
| – | -43.3% | +0.7% | +64.5% | +71.8% | +4.9% | +18.1% | -4.3% | +7.8% | -2.2% | -11.3% | -22.0% | |
| – | +11.0% | +13.1% | +4.8% | +14.0% | -2.9% | +1.9% | +0.3% | +31.2% | -5.7% | +3.9% | +44.4% | |
| – | -11.3% | +9.7% | +20.6% | +34.4% | +4.8% | +7.1% | +1.9% | +18.4% | +2.0% | -5.6% | +2.2% | |
| – | – | -58.1% | -127.3% | – | – | – | – | -993.2% | – | – | – | |
| – | +37.7% | +93.5% | +35.2% | +95.7% | +0.9% | -4.4% | -23.8% | +8.4% | +32.9% | +25.6% | -22.8% | |
| – | – | -63.3% | -157.8% | – | – | – | – | – | – | – | – | |
| – | – | -70.6% | -208.1% | – | -93.9% | -135.7% | – | -12.7% | -42.2% | +117.3% | +15.1% | |
| – | – | -58.1% | -133.0% | – | – | – | – | – | – | – | – | |
| – | +953.8% | -35.0% | -61.6% | -86.6% | +1,385.1% | -26.4% | +179.0% | -93.0% | -1,427.8% | – | +100.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.